Vistra Outperforms Its Industry YTD: Buy, Hold or Sell the Stock? — Positive
VST Zacks Investment Research — November 20, 2025VST stock gains 29.9% year to date as clean energy demand, hedging strength and portfolio expansion fuel its momentum.
DICK'S Set to Report Q3 Results: What to Watch for This Season? — Neutral
DKS Zacks Investment Research — November 20, 2025DKS' Q3 results are expected to reflect improving sales, softer earnings and the impact of strategy, margins and macro pressures.
Seanergy Maritime Holdings (SHIP) Upgraded to Strong Buy: What Does It Mean for the Stock? — Positive
SHIP Zacks Investment Research — November 20, 2025Seanergy Maritime Holdings (SHIP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Genpact (G) Upgraded to Buy: Here's What You Should Know — Positive
G Zacks Investment Research — November 20, 2025Genpact (G) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
What Makes Millicom International Cellular SA (TIGO) a Strong Momentum Stock: Buy Now? — Positive
TIGO Zacks Investment Research — November 20, 2025Does Millicom International Cellular SA (TIGO) have what it takes to be a top stock pick for momentum investors? Let's find out.
TWFG, Inc. (TWFG) Upgraded to Buy: Here's What You Should Know — Positive
TWFG Zacks Investment Research — November 20, 2025TWFG, Inc. (TWFG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Steris (STE) Upgraded to Buy: Here's Why — Positive
STE Zacks Investment Research — November 20, 2025Steris (STE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
What Makes Owlet (OWLT) a New Strong Buy Stock — Positive
OWLT Zacks Investment Research — November 20, 2025Owlet (OWLT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
All You Need to Know About On Holding (ONON) Rating Upgrade to Strong Buy — Positive
ONON Zacks Investment Research — November 20, 2025On Holding (ONON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Pixelworks (PXLW) Upgraded to Buy: Here's Why — Positive
PXLW Zacks Investment Research — November 20, 2025Pixelworks (PXLW) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Parker-Hannifin (PH) Upgraded to Buy: What Does It Mean for the Stock? — Positive
PH Zacks Investment Research — November 20, 2025Parker-Hannifin (PH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Pagaya Technologies Ltd. (PGY) Upgraded to Buy: Here's Why — Positive
PGY Zacks Investment Research — November 20, 2025Pagaya Technologies Ltd. (PGY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Phibro (PAHC) Upgraded to Strong Buy: Here's What You Should Know — Positive
PAHC Zacks Investment Research — November 20, 2025Phibro (PAHC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Moving From TC Energy To The Next Higher Yield And Dividend Growth Bet: ONEOK — Neutral
OKE TRP Seeking Alpha — November 20, 2025TC Energy (TRP) and ONEOK (OKE) are midstream companies that have been moving in different directions in terms of their share prices, resulting in one becoming undervalued. Both names have enjoyed a long history of paying and growing their dividends, and being in the midstream space generally results in higher relative yields as well. While both may be attractive long-term bets, I have recently made a move on OKE and expect my TRP shares to be called away after writing covered calls.
"Hard to Make Bear Case" for NVDA: Can A.I. Giant Keep "Really Insane" Guidance? — Positive
NVDA Schwab Network — November 20, 2025Volatility hit Nvidia (NVDA) late Thursday morning following its earnings report, though Hatem Dhiab sees the company maintaining strength for the long-term. He calls the report "fantastic" and its $500 billion Blackwell guidance "really insane.
Nvidia Corporation delivered strong Q3 '26 earnings, beating expectations and restoring confidence in the AI sector after weeks of market anxiety. NVDA's data center revenue surged 66% year over year, with robust margins and guidance, signaling sustained demand for AI infrastructure. I'm upgrading NVDA stock to a buy as technicals are turning bullish and see a potential for the stock to retest 52-week highs if momentum holds.
Emerson Highlights Strategy for Engineering the Autonomous Future at 2025 Investor Conference — Neutral
EMR PRNewsWire — November 20, 2025Introduces 2028 Financial Targets Reflecting Enhanced Growth and Profitability Announces Plan to Return $10 Billion to Shareholders Through 2028 ST. LOUIS , Nov. 20, 2025 /PRNewswire/ -- Emerson (NYSE: EMR) today hosted its 2025 Investor Conference, during which it outlined its strategic priorities for engineering the autonomous future and introduced new 2028 financial targets.
T. Rowe Price launched four new active fixed income ETFs Thursday, adding to their ever-growing active ETF suite. The four funds include three tax-free ETFs and one “go-anywhere” active bond ETF.
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SKYE — Neutral
SKYE Newsfile Corp — November 20, 2025New York, New York--(Newsfile Corp. - November 20, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.
NNE Outperforms Industry in a Year: Buy, Hold or Sell the Stock? — Neutral
NNE Zacks Investment Research — November 20, 2025NNE's microreactors are in demand amid the rising clean-energy demand from different customer groups.